Go to symposium website → www.slas.org/HighContentAnalysis
avatar for Barrie	Peck, Ph.D.

Barrie Peck, Ph.D.

Barts Cancer Institute
Group Leader
I completed my Ph.D. in breast cancer signalling at Imperial College London in 2010. I then moved to the London Research Institute to the lab of Prof. Almut Schulze to study cancer metabolism. This work focussed on identifying novel cancer-specific dependencies in cancer metabolism. We identified ACSS2 and SCD as fundamental dependencies of aggressive breast and prostate cancers.

In 2014 I moved to the lab of Dr. Rachael Natrajan identifying novel tumour suppressors in breast cancer. We developed bespoke 3-dimensional screening pipelines and discovered novel genes, including CREBBP, KMT2C and NIPBL that impact disease progression and response to targeted therapies.